Overview
Announcements

Ordinary Adjustment | Solactive China Healthcare Disruption Index | Effective 01. June 2021

Solactive China Healthcare Disruption Index:

In the ordinary rebalancing effective open June 01, 2021 the following index composition was implemented:

3SBIO INC 0.787 %
AK MEDICAL HOLDINGS LTD 0.5115 %
AKESO INC 1.7352 %
ALIBABA HEALTH INFORMATION TECHNOLOGY LTD 6.6836 %
ALPHAMAB ONCOLOGY 0.6189 %
BEIGENE LTD 8.6623 %
CANSINO BIOLOGICS INC 4.8942 %
CHINA MEDICAL SYSTEM HOLDINGS LTD 1.6151 %
EVEREST MEDICINES LTD 0.7301 %
GENSCRIPT BIOTECH CORP 1.9562 %
HANSOH PHARMACEUTICAL GROUP CO 6.5854 %
INNOCARE PHARMA LTD 1.17 %
INNOVENT BIOLOGICS INC 4.4923 %
JACOBIO PHARMACEUTICALS GROUP CO LTD 0.5664 %
JD HEALTH INTERNATIONAL INC 7.1197 %
JOINN LABORATORIES CHINA C-H 1.7751 %
KANGJI MEDICAL HOLDINGS LTD 0.5627 %
KINTOR PHARMACEUTICAL LTD 0.8215 %
LIFETECH SCIENTIFIC CORP 0.7799 %
MICROPORT CARDIOFLOW MEDTECH 1.4178 %
MICROPORT SCIENTIFIC CORP 3.8699 %
NEW HORIZON HEALTH LTD 1.0933 %
PEIJIA MEDICAL LTD 0.634 %
PING AN HEALTHCARE AND TECHNOL 3.4334 %
REMEGEN CO LTD-H 1.7957 %
SHANDONG WEIGAO GROUP MEDICAL POLYMER CO LTD 2.5463 %
SHANGHAI JUNSHI BIOSCIENCES CO LTD 3.0225 %
SIMCERE PHARMACEUTICAL GROUP 0.9238 %
SINO BIOPHARMACEUTICAL LTD ORD 5.4028 %
VENUS MEDTECH HANGZHOU INC 1.0365 %
VIVA BIOTECH HOLDINGS 0.6886 %
WUXI APPTEC CO LTD 8.1435 %
WUXI BIOLOGICS CAYMAN INC 8.368 %
YIDU TECH INC 1.2613 %
ZAI LAB LTD 4.2954 %